Gaelle Mercenne is now head of biology for Seattle’s Talus Bioscience. The startup last month announced $11.2 million in new funding to advance its drug discovery program for hard-to-treat diseases.

Fractures of the body of the talus encompass a wide variety of injuries and account for over 25% of all injuries to the talus. [22] No classification scheme categorizes them with clinical ...